Related Experiment Video
Updated: May 31, 2026

Paradigms for Pharmacological Characterization of C. elegans Synaptic Transmission Mutants
Published on: August 18, 2008
Promazine in the treatment of delusional parasitosis
Wiesław Jerzy Cubała1, Katarzyna Jakuszkowiak-Wojten, Anna Burkiewicz
1Department of Psychiatry, Medical University of Gdañsk, Dębinki 7 St. bud. 25, 80-952 Gdañsk, Poland. cubala@gumed.edu.pl
Abstract:
Delusional parasitosis (DP) is an uncommon and complex to treat form of delusional disorder, somatic type. The syndrome may occur in association with a number of psychotic disorders, such as schizophrenia, organic mental disorder, or even in dementia with behavioral and psychological symptoms. Evidence of efficacy of treatment options is weak and there is little known about the specific use of typical and atypical antipsychotics. We report on a case of primary DP in a 75-year-old Caucasian woman with a 3-year-long history of dermatological consultations due to unspecified complains who responded to the typical antipsychotic promazine. This case is unique in pharmacological respect as it presents the first reported DP treatment with promazine. It also raises the issue of efficacy and safety of low-potency typical antipsychotics in the elderly population.
Related Concept Videos
Anthelminthic Agents
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Antiprotozoal Agents
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
